Leading the way in life science technologies

FEEDBURNER Genetics

GEN – Genetic Engineering and Biotechnology News

Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc., celebrating its 40th anniversary in 2021. Renowned for its comprehensive coverage, GEN delivers exclusive insights and analysis across the life sciences, focusing on areas such as drug discovery, bioprocessing, OMICS, translational medicine, and gene editing. The magazine features high-quality reporting on the latest industry news, cutting-edge tools, and scientific advancements, making it an indispensable resource for researchers and executives.

Latest Crypto Articles

  • As we navigate through the complexities of the cryptocurrency arena in late 2024, critical analysis remains at the forefront of investor consciousness. The fundamental shifts in regulatory perspectives, market liquidity, and technological advancements have merited serious examination.

    Read more...

  • The introduction of Bitcoin exchange-traded funds (ETFs) marks a significant transformation in the cryptocurrency landscape. Bitcoin, the pioneering digital asset, has witnessed considerable attention and investment over the past decade, but the recent approval of Bitcoin ETFs has propelled it into the mainstream financial narrative.

    Read more...

  • The cryptocurrency market has been on a remarkable trajectory, breaking through significant resistance levels and showcasing resilience in its growth. As of December 2024, the market has experienced several all-time highs (ATH), marking a transformational phase in its lifespan. 

    Read more...

Tag Cloud